Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. | BMC Cancer | 2021 | 33726687 | PubTator, text mining | PubMed |
| A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes. | Nat Commun | 2021 | 33712626 | PubTator, text mining | PubMed |
| Transcriptional Silencers: Driving Gene Expression with the Brakes On. | Trends Genet | 2021 | 33712326 | PubTator, text mining | PubMed |
| Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma. | Cancer Discov | 2021 | 33707233 | PubTator, text mining | PubMed |
| Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma. | Front Genet | 2021 | 33692827 | PubTator, text mining | PubMed |
| Correlations and Influence of TAP2 Genes Polymorphisms and Systemic Lupus Erythematosus Propensity. | Curr Rheumatol Rev | 2021 | 33687897 | PubTator, text mining | PubMed |
| Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting. | Cell Rep Med | 2021 | 33665637 | PubTator, text mining | PubMed |
| GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients. | iScience | 2021 | 33665568 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms. | Cancers (Basel) | 2021 | 33652860 | PubTator, text mining | PubMed |
| Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing. | Nat Commun | 2021 | 33627649 | PubTator, text mining | PubMed |
| Human natural killer cells in major histocompatibility complex class I deficiency. | Scand J Immunol | 2021 | 33576048 | PubTator, text mining | PubMed |
| LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. | Sci Adv | 2021 | 33568470 | PubTator, text mining | PubMed |
| TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. | Nat Med | 2021 | 33558725 | PubTator, text mining | PubMed |
| Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | 33557271 | PubTator, text mining | PubMed |
| Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigens. | iScience | 2021 | 33554062 | PubTator, text mining | PubMed |
| Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance. | Cell Stress | 2021 | 33554047 | PubTator, text mining | PubMed |
| Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility. | Genome Med | 2021 | 33549134 | PubTator, text mining | PubMed |
| Tumor and Systemic Immunomodulatory Effects of MEK Inhibition. | Curr Oncol Rep | 2021 | 33547983 | PubTator, text mining | PubMed |
| Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. | Nat Commun | 2021 | 33547292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=41